ACL Graft Market Overview

The global ACL Graft Market was valued at USD 312.58 million, registering a CAGR of 7.8% during 2025–2030. The market growth is primarily driven by the increasing elderly population, as aging is associated with a higher incidence of musculoskeletal injuries, including anterior cruciate ligament (ACL) damage.

Download Free Sample

In North America, market growth is supported by the high prevalence of sports-related injuries, particularly among athletes involved in high-impact activities such as football, basketball, and skiing. Rising awareness of advanced treatment options, coupled with the availability of well-established healthcare infrastructure and skilled orthopedic surgeons, is driving the adoption of ACL graft procedures. Additionally, increasing participation in recreational sports, an aging population prone to knee injuries, and the growing use of minimally invasive surgical techniques are further fueling market expansion.

Key players in the global ACL graft market include RTI Surgical, Allosource, MTF Biologics, Lifenet Health, Arthrex, Inc., Zimmer Biomet, and Medtronic. These companies are focusing on product innovation, advanced surgical solutions, and expanding their global footprint to address the rising demand for ACL repair and reconstruction procedures